by telrheum | Sep 9, 2024 | Autoimmune Diseases, Interstitial Lung Disease, Sjögren’s Syndrome
This study explores whether the presence of certain antibodies (anti-SSa and Ro52) affects the progression of lung disease (interstitial lung disease or ILD) in people with idiopathic inflammatory myopathies (IIM). These antibodies are often found in individuals with...
by telrheum | Aug 9, 2024 | Autoimmune Diseases, Connective Tissue Diease, Interstitial Lung Disease, Rheumatoid Arthritis, Sjögren’s Syndrome, Systemic Sclerosis
This study focuses on a treatment for patients with connective tissue diseases (CTD) who also have a lung condition called interstitial lung disease (ILD). This condition, when it becomes progressive and fibrosing (PF-ILD), can lead to serious lung damage. The...
by telrheum | May 27, 2024 | Sjögren’s Syndrome, Systemic Sclerosis
Study Background: This research focuses on finding reliable blood biomarkers to diagnose Interstitial Lung Disease (ILD) in patients with autoimmune diseases, specifically rheumatoid arthritis (RA) and systemic sclerosis (SSc). ILD is a serious complication in these...
by telrheum | Apr 6, 2024 | Biologic Therapy, Sjögren’s Syndrome
Dazodalibep (DAZ) is a special type of protein used to treat Sjögren’s disease, which affects the immune system. In a study, patients with this disease took DAZ or a placebo (a treatment with no active drug) to see how effective and safe DAZ is. The study was...
by telrheum | Mar 30, 2024 | Autoimmune Diseases, Infections, Lymphoma, Sjögren’s Syndrome
The article “35 Years Follow-up of Primary Sjögren’s Disease: A Single Center Study” by Lorena Montano-Tapia and colleagues is a long-term study of patients with Primary Sjögren’s Syndrome (pSS), an autoimmune disease affecting exocrine glands. Conducted at the...
